Thus, hyperuricemia stands as a potential contributing agent to obesity, and augmentation of HO-1 offers a promising avenue in attenuating adipocyte dysfunction. The gene discussed is HMOX1; the disease is obesity due to melanocortin 4 receptor deficiency.